593 Treating chronic hepatitis C with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin in routine clinical practice: Factors predicting SVR using multiple logistic regression analysis Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Lee, SS
  • Powis, J
  • Heathcote, EJ
  • Sherman, M
  • Bailey, RJ
  • Feinman, SV
  • Baro, V
  • Yoshidas, E
  • Witt-Sullivan, Helga
  • Peltekian, K

publication date

  • April 2006